Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer. [electronic resource]
Producer: 20200819Description: 5061-5068 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents, Immunological -- administration & dosage
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Female
- Humans
- Immunohistochemistry
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Molecular Targeted Therapy
- Neoplasm Grading
- Neoplasm Metastasis
- Neoplasm Staging
- Treatment Outcome
- Exome Sequencing
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.